Baudu Ariane, Prétet Jean-Luc, Riethmuller Didier, Chotard Morgane, Mougin Christiane, Mercier Mariette
Univ Franche-Comte, F-25000 Besancon, France; EA 3181, FED4234, F-25000 Besancon, France.
Univ Franche-Comte, F-25000 Besancon, France; EA 3181, FED4234, F-25000 Besancon, France; CHU Besancon, F-25000, France.
J Epidemiol Glob Health. 2014 Mar;4(1):35-43. doi: 10.1016/j.jegh.2013.11.003. Epub 2014 Jan 23.
Investigation of the prevalence and risk factors of human papillomavirus (HPV) infection is the basis for developing prophylactic strategies against cervical cancer, especially for young women. This study aimed to assess the prevalence and risk factors of HPV infection among a cohort of sexually active young French women eligible for catch-up vaccination. Between 1997 and 2007, 2163 women aged 15-23 years attending consultations at the department of gynecology in the Hospital of Besançon (France) were screened for high risk HPV (HR HPV) infection. Risk factors were investigated through a questionnaire sent to all participants in 2010. HPV DNA was detected by HC2 and Probe Set assays. The overall prevalence for HR HPV and HPV16, 18 and/or HPV45 was 44.6% (95% CI, 42.5-46.7%) and 19% (95% CI, 17.3-20.7%), respectively. The response rate to the questionnaire was 22.6%. The prevalence of independent risk factors (age older than 19, smoking, and oral contraception) for HPV 16/18/45 infection in this population was less than 20%. Based on this study, HPV vaccination should be offered not only to teenage girls, but also to young women, regardless of their sexual activity.
对人乳头瘤病毒(HPV)感染的患病率及危险因素进行调查是制定宫颈癌预防策略的基础,对于年轻女性而言尤为如此。本研究旨在评估一组符合补种疫苗条件、有性活动的法国年轻女性中HPV感染的患病率及危险因素。1997年至2007年间,对法国贝桑松医院妇科门诊的2163名年龄在15至23岁的女性进行了高危型HPV(HR HPV)感染筛查。2010年通过向所有参与者发放问卷对危险因素进行了调查。采用HC2和探针组检测法检测HPV DNA。HR HPV以及HPV16、18和/或HPV45的总体患病率分别为44.6%(95%可信区间,42.5 - 46.7%)和19%(95%可信区间,17.3 - 20.7%)。问卷的回复率为22.6%。该人群中HPV 16/18/45感染的独立危险因素(年龄大于19岁、吸烟和口服避孕药)的患病率低于20%。基于本研究,HPV疫苗接种不仅应提供给少女,也应提供给年轻女性,无论其性活动情况如何。